Shunbin Ning Selected Research

Shunbin Ning Research Topics

Disease

12	Virus Diseases (Viral Diseases) 01/2022 - 04/2005
10	Neoplasms (Cancer) 01/2022 - 08/2011
8	HIV Infections (HIV Infection) 01/2022 - 01/2019
8	Infections 01/2022 - 04/2005
5	Carcinogenesis 01/2022 - 08/2011
4	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2020 - 01/2018
3	Epstein-Barr Virus Infections 06/2010 - 09/2003
2	Bites and Stings (Sting) 10/2021 - 01/2019
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2021 - 01/2017
2	COVID-19 10/2021 - 10/2021
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Chronic Hepatitis C 12/2020 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 09/2013
2	Lymphoma (Lymphomas) 01/2018 - 08/2017
1	Immune System Diseases (Immune Disorders) 11/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 10/2021
1	Adenocarcinoma of Lung 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2020
1	Persistent Infection 01/2020
1	Viremia 01/2019
1	Latent Infection 01/2018
1	Lung Neoplasms (Lung Cancer) 08/2017
1	Prostatic Neoplasms (Prostate Cancer) 08/2017
1	Glioblastoma (Glioblastoma Multiforme) 08/2017
1	Breast Neoplasms (Breast Cancer) 08/2017
1	Aicardi-Goutieres syndrome 05/2015
1	Leukemia 08/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2011
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 08/2011
1	T-Cell Leukemia (Leukemia, T Cell) 08/2011
1	Hairy Leukoplakia 08/2005

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
5	Antiviral Agents (Antivirals)IBA 12/2020 - 04/2005
5	InterferonsIBA 10/2016 - 04/2005
4	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2019
4	Transcription Factors (Transcription Factor)IBA 10/2021 - 09/2013
4	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2011
4	Long Noncoding RNAIBA 01/2021 - 12/2020
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 01/2019
3	Phosphotransferases (Kinase)IBA 10/2021 - 01/2019
3	VaccinesIBA 10/2021 - 01/2018
2	UbiquitinIBA 10/2021 - 06/2010
2	Messenger RNA (mRNA)IBA 01/2021 - 08/2011
2	sodium arsenite (sodium metaarsenite)IBA 12/2020 - 01/2019
2	EnzymesIBA 01/2020 - 01/2019
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2019 - 01/2019
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018 - 09/2015
2	RNA (Ribonucleic Acid)IBA 08/2017 - 05/2015
2	Oncogene Proteins (Oncogene Protein)IBA 09/2015 - 09/2003
2	imidazole mustard (BIC)IBA 09/2013 - 08/2011
2	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 08/2005 - 09/2003
1	Telomere-Binding ProteinsIBA 01/2022
1	CateninsIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2021
1	Neutralizing AntibodiesIBA 10/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	Immunoglobulin G (IgG)IBA 10/2021
1	ArginaseIBA 12/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2020
1	Mitochondrial DNA (mtDNA)IBA 12/2020
1	Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Nuclear Respiratory Factor 1IBA 12/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	Integrase InhibitorsIBA 10/2020
1	Raltegravir Potassium FDA Link 10/2020
1	tyrosyl-DNA phosphodiesteraseIBA 01/2020
1	Cancer VaccinesIBA 01/2019
1	NitrogenIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Checkpoint Kinase 2IBA 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2019
1	CamptothecinIBA 01/2019
1	DNA Repair EnzymesIBA 01/2018
1	Viral RNAIBA 01/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017
1	Factor VII (Proconvertin)IBA 10/2016
1	Serine (L-Serine)FDA Link 10/2016
1	Toll-Like Receptor 7IBA 10/2016
1	Interleukin-10 (Interleukin 10)IBA 09/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015
1	Caspase 3 (Caspase-3)IBA 09/2015
1	CytokinesIBA 09/2015
1	Biological ProductsIBA 09/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2015
1	Interferon Regulatory FactorsIBA 09/2013
1	CREB-Binding ProteinIBA 04/2005
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2003

Therapy/Procedure

4	Therapeutics 10/2021 - 01/2019
4	Immunomodulation 12/2020 - 01/2019
2	Art Therapy 01/2021 - 10/2020
2	Immunotherapy 01/2018 - 01/2018